ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 168 filers reported holding ACCELERON PHARMA INC in Q2 2019. The put-call ratio across all filers is 1.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $13,606,000 | -67.9% | 79,059 | -76.6% | 0.04% | -37.7% |
Q2 2021 | $42,416,000 | +70.6% | 338,010 | +84.4% | 0.06% | -19.7% |
Q1 2021 | $24,858,000 | -15.9% | 183,300 | -20.6% | 0.08% | -18.3% |
Q4 2020 | $29,543,000 | +9.1% | 230,914 | -4.0% | 0.09% | -5.1% |
Q3 2020 | $27,081,000 | -41.8% | 240,657 | -50.7% | 0.10% | +6.5% |
Q2 2020 | $46,552,000 | +24.1% | 488,630 | +17.0% | 0.09% | -2.1% |
Q1 2020 | $37,526,000 | +38.8% | 417,570 | -18.1% | 0.09% | +70.9% |
Q4 2019 | $27,034,000 | -6.5% | 509,870 | -30.4% | 0.06% | -5.2% |
Q3 2019 | $28,926,000 | -5.1% | 732,104 | -1.3% | 0.06% | -3.3% |
Q2 2019 | $30,478,000 | +117.9% | 741,910 | +147.0% | 0.06% | +9.1% |
Q1 2019 | $13,986,000 | +367.3% | 300,314 | +336.9% | 0.06% | +323.1% |
Q4 2018 | $2,993,000 | +33.3% | 68,735 | +75.3% | 0.01% | +62.5% |
Q3 2018 | $2,245,000 | -64.4% | 39,220 | -69.8% | 0.01% | -66.7% |
Q2 2018 | $6,310,000 | -30.9% | 130,055 | -44.3% | 0.02% | -33.3% |
Q1 2018 | $9,130,000 | -20.0% | 233,504 | -13.1% | 0.04% | -20.0% |
Q4 2017 | $11,409,000 | +13.6% | 268,815 | -0.1% | 0.04% | +4.7% |
Q3 2017 | $10,043,000 | +2.1% | 269,092 | -16.8% | 0.04% | -4.4% |
Q2 2017 | $9,833,000 | – | 323,555 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |